Double Medical Technology (SZSE:002901) ROCE % : 14.28% (As of Sep. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Double Medical Technology ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Double Medical Technology's annualized ROCE % for the quarter that ended in Sep. 2024 was 14.28%.

Double Medical Technology ROCE % Historical Data

The historical data trend for Double Medical Technology's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Double Medical Technology ROCE % Chart

Double Medical Technology Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

33.43

35.32

33.06

5.12

3.19

Double Medical Technology Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															2.87	-3.11	8.96	10.11	14.28

Double Medical Technology ROCE % Calculation

Double Medical Technology's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	106.899	/	( ( (3937.518 - 716.603)	+	(4639.741 - 1153.675) )	/ 2 )
	=	106.899	/	( (3220.915	+	3486.066)	/ 2 )
	=	106.899	/	3353.4905
	=	3.19 %

Double Medical Technology's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	502.412	/	( ( (4483.036 - 995.603)	+	(4460.832 - 913.001) )	/ 2 )
	=	502.412	/	( ( 3487.433	+	3547.831 )	/ 2 )
	=	502.412	/	3517.632
	=	14.28 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Double Medical Technology (SZSE:002901) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Double Medical Technology ROCE % Related Terms

Thank you for viewing the detailed overview of Double Medical Technology's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Double Medical Technology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Double Medical Technology Inc (SZSE:002901) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 18, Hongdong Road, Haicang District, Fujian Province, Shanbian, Xiamen, CHN, 361027

Website

http://www.double-medical.com

Double Medical Technology Inc provides services and devices in the areas of orthopedics, wound management, neurosurgery, and general surgery. It offers product related to Trauma, Spinal and joint. The business activities are carried out through China.

Executives

Chen Dan He	Executives
Han Shao Jian	Executives
Ruan Dong Yang	Executives
Luo Jiong	Directors, executives
Hua Xian Nan	Secretary Dong
Li Hui	Independent director
Zhan Huan Huan	Supervisors

Double Medical Technology Headlines

No Headlines